Congress is running out of time to pass a budget bill to continue funding the government, and funding for vital cancer research and prevention programs is at risk.
A new report found that a 10% cut to research funding could lower the number of new drugs that become available to cancer patients to fight the disease over the next three decades and beyond. A recent proposal calls for cuts that are four times bigger.
Stories help demonstrate why cancer research funding is so important. If you've been impacted by advancements in cancer research or recent cuts to clinical trials, we want to hear from you.
By passing the Clinical Trial Modernization Act, Congress can remove barriers to clinical trial participation and ensure more cancer patients have access to the latest scientific advancements and cutting-edge treatments.
